Cover: Managed Care and the Evaluation and Adoption of Emerging Medical Technologies

Managed Care and the Evaluation and Adoption of Emerging Medical Technologies

Executive Summary

Published 2000

by Steven Garber, M. Susan Ridgely, Roger Taylor, Robin Meili


Download Free Electronic Document

FormatFile SizeNotes
PDF file 0.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.


Purchase Print Copy

 Format Price
Add to Cart Paperback14 pages $8.00

New medical technologies — pharmaceuticals, medical devices, and procedures — often allow great improvements in the outcomes of medical care, but they are also widely believed to be a major cause of increasing costs. Selective adoption of new technologies is crucial in the quest to control health care costs while preserving or enhancing the quality of care. This report focuses on evaluation and adoption of innovative procedures and medical devices by managed care organizations (MCOs). The project had two primary objectives: (1) to understand current MCO processes for making coverage, medical-necessity, and payment decisions and how device developers and manufacturers prepare for and participate in these processes; and (2) to identify ways that private, voluntary action by the managed-care and medical-device industries might improve — for the benefit of society — these processes. The core data are from confidential interviews with eight companies that develop and manufacture medical devices and medical directors of nine MCOs. The findings should be of interest to medical-device developers and manufacturers, managed care organizations, public-policy makers, and researchers and analysts. A major impediment to socially appropriate adoption of emerging medical technologies is limited information about the performance of these technologies in day-to-day medical practice. The authors discuss prospects for improving four elements of information availability:

  1. Developing better information before market introduction
  2. Learning more from experience after market introduction
  3. Evaluating and synthesizing clinical information
  4. Disseminating information.

They also discuss several other issues that warrant consideration:

  • Aligning private incentives of MCOs and payers with social values
  • Enhancing MCO capabilities to evaluate technologies and make decisions
  • Improving decisions by physicians
  • Reducing use of inappropriate or obsolete technologies
  • Reducing costs of decisionmaking for manufacturers and MCOs
  • Improving manufacturer understanding of the market environment
  • helping MCOs and employers anticipate what is in the pipeline.

This report is part of the RAND monograph report series. The monograph/report was a product of RAND from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.